Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EF7V
|
||||
Former ID |
DNC004493
|
||||
Drug Name |
Ro-31-4724
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Terminated | [534482] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H35N3O6
|
||||
Canonical SMILES |
CCOC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)CC(=O)NO
|
||||
InChI |
1S/C19H35N3O6/c1-7-28-19(26)13(6)20-18(25)15(9-12(4)5)21-17(24)14(8-11(2)3)10-16(23)22-27/h11-15,27H,7-10H2,1-6H3,(H,20,25)(H,21,24)(H,22,23)/t13-,14+,15-/m0/s1
|
||||
InChIKey |
XKRONJXEXGFBRZ-ZNMIVQPWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Interstitial collagenase | Target Info | Inhibitor | [527073] | |
PANTHER Pathway | Alzheimer disease-presenilin pathway | ||||
Plasminogen activating cascade | |||||
WikiPathways | TGF beta Signaling Pathway | ||||
Bladder Cancer | |||||
Activation of Matrix Metalloproteinases | |||||
Degradation of collagen | |||||
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||||
Oncostatin M Signaling Pathway | |||||
Prostate Cancer | |||||
Integrated Breast Cancer Pathway | |||||
Integrated Cancer pathway | |||||
Cell surface interactions at the vascular wall | |||||
Matrix Metalloproteinases | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.